Esketamine vs crisis planning vs usual care for suicide prevention
Part of Mental health clinical trials.
This trial compares three approaches to help people who recently tried to kill themselves or have strong suicidal thoughts: a nasal spray called esketamine, a personalized crisis response plan, or the best standard care available. It aims to find which method works best for preventing future suicide attempts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years old or older.
- You came to a public emergency room in Indaiatuba or São Paulo, Brazil.
- You have tried to kill yourself in the last 30 days, or had a suicide attempt that was interrupted or stopped.
- You are having strong thoughts about suicide right now, with a plan or intent to act.
- You live in the study city (Indaiatuba or São Paulo) so you can come back for follow-up visits.
- You are not pregnant or breastfeeding (if female and could become pregnant), and you do not have certain medical conditions that make esketamine unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ketamine plus a structured crisis-response plan can help reduce suicidal thoughts for adults admitted from the ER. It also aims to make care in the emergency setting more consistent and effective.
This Phase 3 study tests ketamine to reduce ongoing suicidal thoughts and help prevent another suicide attempt in youth after a recent attempt. It will compare ketamine treatment against standard care to see if it helps improve safety and reduce suicide risk.
This study tests combining a specific type of therapy (BCBT-SP) with esketamine nasal spray to help people with treatment-resistant depression who are having ongoing suicidal thoughts. The goal is to see if this combination can reduce suicidal ideation more effectively than either treatment alone.
This trial tests if esketamine (a nasal spray) can quickly reduce symptoms of major depression and suicidal thoughts in teenagers who need urgent hospital care.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This trial studies how ketamine affects the brain in people dealing with suicidal thoughts or an active suicide crisis. It uses questionnaires, consent testing, and brain imaging to look for biological changes that may relate to symptom improvement.
Hear when a new Suicide Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.